2011
DOI: 10.1016/j.tetlet.2011.01.086
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of C1–C20 and C21–C40 fragments of tetrafibricin

Abstract: Efficient syntheses of suitably functionalized top and bottom fragments of tetrafibricin are described. The bottom fragment is prepared by two consecutive Kocienski-Julia couplings, while the top fragment synthesis features a dithiane alkylation and a Horner-Wadsworth-Emmons reaction.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
9
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 22 publications
0
9
0
Order By: Relevance
“…Then, sequential coupling of these building blocks, choosing the correct configuration at each stage, would allow for preparation of any diastereomeric 1,5-polyol with equal facility, using the same coupling chemistry. For the coupling reactions, we chose the reliable Julia–Kocienski method, , using reagents readily available to most practitioners. Each building block would need sulfone and aldehyde termini, as depicted in α-siloxy-γ-sulfonyl aldehyde building block 1 (Scheme ), with the aldehyde in latent form.…”
Section: Introductionmentioning
confidence: 99%
“…Then, sequential coupling of these building blocks, choosing the correct configuration at each stage, would allow for preparation of any diastereomeric 1,5-polyol with equal facility, using the same coupling chemistry. For the coupling reactions, we chose the reliable Julia–Kocienski method, , using reagents readily available to most practitioners. Each building block would need sulfone and aldehyde termini, as depicted in α-siloxy-γ-sulfonyl aldehyde building block 1 (Scheme ), with the aldehyde in latent form.…”
Section: Introductionmentioning
confidence: 99%
“…Tetrafibricin (Figure ), isolated from Streptomyces neyagawaensis NR0577 in 1993, is a potent nonpeptidic fibrinogen receptor antagonist (IC 50 = 46 n m ) that inhibits platelet aggregation by blocking GPIIb/IIIa receptors, which makes it a potential drug candidate for arterial thrombotic diseases . Since its stereochemical structure elucidation in 2003 through an NMR spectroscopic database approach, strategies toward the synthesis of tetrafibricin have generated considerable interest; the laboratories of Cossy, Curran, and Krische each reported preparations of various fragments of the natural product. Studies from the Roush group led to a synthesis of N ‐acetyl dihydrotetrafibricin methyl ester.…”
Section: Introductionmentioning
confidence: 99%
“…Tetrafibricin has garnered interest with regard to the study of fibrinogen binding, platelet aggregation, and as a treatment for arterial thrombosis, , which in turn has evoked interest in its preparation via total synthesis. Despite efforts reported from the laboratories of Cossy, Curran, Friestad, Roush, and the present author, including syntheses of a protected derivative of the natural product by Curran and of N -acetyl dihydrotetrafibricin methyl ester by Roush, the total synthesis of tetrafibricin remains an unmet challenge.…”
mentioning
confidence: 99%